EligibleTrials
Drugs & treatments › Zanzalintinib

Zanzalintinib: clinical trials recruiting now

3
Recruiting trials
15
Conditions studied
34
US states with sites
19
Countries

Phase breakdown

Phase 1 1 Phase 2 2 Phase 3 1

Conditions being studied

ConditionTrials
Prostate cancer2
Aggressive Variant Prostate Carcinoma1
Clear Cell Renal Cell Carcinoma (ccRCC)1
Colorectal Cancer (CRC)1
Colorectal cancer1
Drug-Drug Interaction (DDI)1
Extra-Pancreatic Neuroendocrine Tumor (epNET)1
Head and Neck Squamous Cell Carcinoma (HNSCC)1
Hepatocellular Carcinoma (HCC)1
Lung cancer1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)1
Non-Clear Cell Renal Cell Carcinoma (nccRCC)1
Non-small Cell Lung Cancer (NSCLC)1
Pancreatic Neuroendocrine Tumor (pNET)1
Pancreatic cancer1

Recruiting trials involving Zanzalintinib

Common questions

How many recruiting trials involve Zanzalintinib?

3 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.